- Home
- NRO vs BWAY Comparison
NRO vs BWAY Comparison
Compare NRO & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- BWAY
- Stock Information
- Founded
- NRO 2003
- BWAY 2003
- Country
- NRO United States
- BWAY Israel
- Employees
- NRO N/A
- BWAY N/A
- Industry
- NRO Finance/Investors Services
- BWAY Medical/Dental Instruments
- Sector
- NRO Finance
- BWAY Health Care
- Exchange
- NRO Nasdaq
- BWAY Nasdaq
- Market Cap
- NRO 170.5M
- BWAY 177.4M
- IPO Year
- NRO N/A
- BWAY 2019
- Fundamental
- Price
- NRO $3.31
- BWAY $10.28
- Analyst Decision
- NRO
- BWAY Strong Buy
- Analyst Count
- NRO 0
- BWAY 3
- Target Price
- NRO N/A
- BWAY $13.17
- AVG Volume (30 Days)
- NRO 239.4K
- BWAY 57.5K
- Earning Date
- NRO 01-01-0001
- BWAY 03-05-2025
- Dividend Yield
- NRO 11.41%
- BWAY N/A
- EPS Growth
- NRO N/A
- BWAY N/A
- EPS
- NRO N/A
- BWAY 0.04
- Revenue
- NRO N/A
- BWAY $38,631,000.00
- Revenue This Year
- NRO N/A
- BWAY $388.82
- Revenue Next Year
- NRO N/A
- BWAY $18.70
- P/E Ratio
- NRO N/A
- BWAY $128.37
- Revenue Growth
- NRO N/A
- BWAY 34.19
- 52 Week Low
- NRO $2.51
- BWAY $4.61
- 52 Week High
- NRO $3.45
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- NRO 38.13
- BWAY 46.35
- Support Level
- NRO $3.33
- BWAY $10.24
- Resistance Level
- NRO $3.45
- BWAY $10.89
- Average True Range (ATR)
- NRO 0.07
- BWAY 0.47
- MACD
- NRO -0.01
- BWAY -0.04
- Stochastic Oscillator
- NRO 5.56
- BWAY 10.34
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.